Diarrhea and Stipsis in Critically Ill Patients (NUTRITI)

NCT ID: NCT05473546

Last Updated: 2022-07-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-10-11

Study Completion Date

2022-07-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study prospectively observed the complications intended as diarrhea or sti-sis that critically ill patients developed within 7 days after ICU admission.

In addition, secondary aims investigated through bioimpedenziometry the loss of lean body mass and changes in phase angle during the same period of ICU stay.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness Nutritional and Metabolic Disease Nutritional Deficiency ICU Acquired Weakness Enteral Feeding Intolerance Diarrhea Constipation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CRITICALLY ILL PATIENTS

ADULTS PATIENTS ADMITTED TO ICU DUE TO ACUTE ILLNESS THAT REQUIRE AT LEAST 72H OF STAY.

FOR THE FIRST 7 DAYS OF STAY IN ICU, DATA ABOUT NUTRITIONAL INTERVENTION WILL BE RECORDED SUCH AS: ROUTE OF NUTRITION ADMINISTRATION, AMOUNT OF NUTRITION DELIVERED PER DAY, CALORIC TARGETS, PROTEIN REQUIREMENTS, diarrhea, CONSTIPATION, BIA ANALYSIS.

ARTIFICIAL NUTRITION

Intervention Type OTHER

ARTIFICIAL NUTRITION

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ARTIFICIAL NUTRITION

ARTIFICIAL NUTRITION

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ICU ANTICIPATED LENGTH OF STAY \> 72 HOURS
* AGE \> 18 YEARS
* NEED FOR ARTIFICIAL NUTRITION

Exclusion Criteria

* AGE \< 18 YEARS
* ICU ANTICIPATED LENGTH OF STAY \< 72 HOURS
* NO NEED FOR ARTIFICIAL NUTRITION
* BMI\<16 KG/M2
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Azienda Sanitaria-Universitaria Integrata di Udine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cristian Deana

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

CRISTIAN DEANA, MD

Role: PRINCIPAL_INVESTIGATOR

Health Integrated Agency of Friuli Centrale, via Pozzuolo 330, 33100 Udine, Italy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cristian Deana

Udine, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

References

Explore related publications, articles, or registry entries linked to this study.

Danielis M, Mattiussi E, Piani T, Iacobucci A, Tullio A, Molfino A, Vetrugno L, Deana C; Nutriti Study Group. Diarrhoea and constipation during artificial nutrition in intensive care unit: A prospective observational study. Clin Nutr ESPEN. 2023 Oct;57:375-380. doi: 10.1016/j.clnesp.2023.07.007. Epub 2023 Jul 20.

Reference Type DERIVED
PMID: 37739681 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NUTRITI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Refeeding Syndrome in Cancer Patients
NCT02534181 WITHDRAWN PHASE2